Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

Both of Tesla's previous stock splits happened during the month of August -- but don't expect another one to happen two ...

Stock splits are no longer as routine as they were a couple of decades ago, but a string of high-profile ones has put the subject back in the spotlight. In 2025, Netflix (NASDAQ:NFLX) executed a ...

Stock splits stir up a lot of noise in the world of investing. A stock split doesn’t change the value of a company but can influence investor sentiment and market activity. That said, a stock split ...

Splits aren't an explicit buy signal. PEGA and IBKR are two recent examples of splits. Splits help knock down barriers of entry. We’ve seen many notable splits in recent years, with companies aiming ...

Yesterday, Banzai International, Inc. (NASDAQ:BNZI) announced a 1‑for‑10 reverse stock split, set to take effect July 8, 2025. Here’s a comprehensive guide explaining what that means—and how similar ...

These companies decided on stock splits after periods of fantastic stock performance. A stock split lowers the per-share price but doesn’t change anything fundamental about the company. These 10 ...

The operation should make it easier for a broader range of investors to buy the stock.

Stock splits usually give you many more shares. But the total value of your stake in the company won't change much. There are more important considerations than stock splits, when you're stock-hunting ...

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance, Inc. (Nasdaq: AIFA) (the “Company” or “AIFA”) today announced that, at its Special Meeting of Stockholders held on June 1, 2026 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NEW YORK--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...